Also. . .
Medtronic Inc., the No. 1 pacemaker manufacturer, said it withdrew its offer to buy Cybertronics Inc., a maker of devices to treat epilepsy, for about $480 million in stock, after talks fell apart.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
